• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从荟萃分析和药物警戒不稳定性分析中获得的药物不良反应风险在大多数情况下是相关的。

Adverse drug reaction risks obtained from meta-analyses and pharmacovigilance disproportionality analyses are correlated in most cases.

机构信息

Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France; Clinical Pharmacology Department INSERM CIC1406, Grenoble Alpes University Hospital, Grenoble, France; UMR 1042-HP2, INSERM, Univ. Grenoble Alpes, Grenoble, France.

Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France.

出版信息

J Clin Epidemiol. 2021 Jun;134:14-21. doi: 10.1016/j.jclinepi.2021.01.015. Epub 2021 Jan 26.

DOI:10.1016/j.jclinepi.2021.01.015
PMID:33508405
Abstract

OBJECTIVE

We aimed at testing if a correlation between adverse drug reactions relative risks estimated from meta-analyses and disproportionality analyses calculated from pharmacovigilance spontaneous reporting systems databases exist, and if methodological choices modify this correlation.

STUDY DESIGN

We extracted adverse drug reactions (ADR) odds ratios (ORs) from meta-analyses used as reference and calculated corresponding Reporting Odds Ratios (RORs) from the WHO pharmacovigilance database according to five different designs. We also calculated the relative bias and agreement of ROR compared to ORs.

RESULTS

We selected five meta-analyses which displayed a panel of 13 ADRs. A significant correlation for 7 out of the 13 ADRs studied in the primary analysis was found. The methods for ROR calculation impacted the results but none systematically improved the correlations. Whereas correlation was found between OR and ROR, agreement was poor and relative bias was important.

CONCLUSION

Despite the large variation in disproportionality analyses results due to design specification, this study provides further evidence that relative risks obtained from meta-analyses and from disproportionality analyses correlate in most cases, in particular for objective ADR not associated with the underlying pathology.

摘要

目的

本研究旨在检验从荟萃分析中估计的药物不良反应(ADR)相对风险与从药物警戒自发报告系统数据库中计算的比例失调分析之间是否存在相关性,以及方法学选择是否会改变这种相关性。

设计

我们从荟萃分析中提取了作为参考的ADR 比值比(OR),并根据五种不同的设计,从世界卫生组织药物警戒数据库中计算了相应的报告比值比(ROR)。我们还计算了 ROR 与 OR 相比的相对偏差和一致性。

结果

我们选择了五项荟萃分析,其中展示了 13 种 ADR 的面板。在主要分析中,研究的 13 种 ADR 中有 7 种显示出显著相关性。ROR 计算方法对结果有影响,但没有一种方法能系统地改善相关性。虽然 OR 和 ROR 之间存在相关性,但一致性较差,相对偏差较大。

结论

尽管由于设计规范的不同,比例失调分析的结果存在很大差异,但本研究进一步证明了荟萃分析和比例失调分析中获得的相对风险在大多数情况下是相关的,特别是对于与潜在病理无关的客观 ADR。

相似文献

1
Adverse drug reaction risks obtained from meta-analyses and pharmacovigilance disproportionality analyses are correlated in most cases.从荟萃分析和药物警戒不稳定性分析中获得的药物不良反应风险在大多数情况下是相关的。
J Clin Epidemiol. 2021 Jun;134:14-21. doi: 10.1016/j.jclinepi.2021.01.015. Epub 2021 Jan 26.
2
Adverse Drug Reaction Risk Measures: A Comparison of Estimates from Drug Surveillance and Randomised Trials.药物不良反应风险测量:药物监测与随机试验估计值的比较
Pharmaceut Med. 2019 Aug;33(4):331-339. doi: 10.1007/s40290-019-00287-y.
3
Signal detection for Thai traditional medicine: examination of national pharmacovigilance data using reporting odds ratio and reported population attributable risk.泰国传统医学的信号检测:使用报告比值比和报告的人群归因风险对国家药物警戒数据进行审查。
Regul Toxicol Pharmacol. 2014 Oct;70(1):407-12. doi: 10.1016/j.yrtph.2014.06.007. Epub 2014 Jun 16.
4
High prevalence of spin was found in pharmacovigilance studies using disproportionality analyses to detect safety signals: a meta-epidemiological study.在使用不成比例分析来检测安全信号的药物警戒研究中发现自旋的高患病率:一项元流行病学研究。
J Clin Epidemiol. 2021 Oct;138:73-79. doi: 10.1016/j.jclinepi.2021.06.022. Epub 2021 Jun 26.
5
Safety concerns reported by consumers, manufacturers and healthcare professionals: A detailed evaluation of opioid-related adverse drug reactions in the FDA database over 15 years.消费者、制造商和医疗保健专业人员报告的安全问题:对 FDA 数据库中超过 15 年的阿片类药物相关不良反应的详细评估。
Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1627-1635. doi: 10.1002/pds.5105. Epub 2020 Aug 26.
6
A meta-epidemiological study found lack of transparency and poor reporting of disproportionality analyses for signal detection in pharmacovigilance databases.一项荟萃流行病学研究发现,药物警戒数据库中信号检测的不均衡分析缺乏透明度和报告质量较差。
J Clin Epidemiol. 2021 Nov;139:191-198. doi: 10.1016/j.jclinepi.2021.07.014. Epub 2021 Jul 27.
7
Case-non-case studies: Principle, methods, bias and interpretation.病例-非病例研究:原理、方法、偏倚与解读
Therapie. 2019 Apr;74(2):225-232. doi: 10.1016/j.therap.2019.01.006. Epub 2019 Jan 31.
8
Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database.抗病毒药物的安全性概况:使用意大利自发报告数据库的药物警戒研究。
Am J Health Syst Pharm. 2013 Jun 15;70(12):1039-46. doi: 10.2146/ajhp120665.
9
The value of time-to-onset in statistical signal detection of adverse drug reactions: a comparison with disproportionality analysis in spontaneous reports from the Netherlands.药物不良反应统计信号检测中发病时间的价值:与荷兰自发报告中的不成比例分析比较
Pharmacoepidemiol Drug Saf. 2016 Dec;25(12):1361-1367. doi: 10.1002/pds.4115. Epub 2016 Sep 30.
10
IL-4/13 Blockade and sleep-related adverse drug reactions in over 37,000 Dupilumab reports from the World Health Organization Individual Case Safety reporting pharmacovigilance database (VigiBase™): a big data and machine learning analysis.IL-4/13 阻断剂与超过 37000 例度普利尤单抗报告中的睡眠相关药物不良反应:来自世界卫生组织个体病例安全报告药物警戒数据库(VigiBase™)的大数据和机器学习分析。
Eur Rev Med Pharmacol Sci. 2022 Jun;26(11):4074-4081. doi: 10.26355/eurrev_202206_28977.

引用本文的文献

1
Is it appropriate to conduct a disproportionality analysis using a spontaneous reporting database to investigate whether drug-related adverse events are dose-dependent?使用自发报告数据库进行不成比例分析以调查药物相关不良事件是否与剂量相关是否合适?
Front Pharmacol. 2025 Aug 29;16:1563524. doi: 10.3389/fphar.2025.1563524. eCollection 2025.
2
Drug-induced sinusoidal obstruction syndrome: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System (FEARS).药物性窦性阻塞综合征:一项基于美国食品药品监督管理局不良事件报告系统(FEARS)的真实世界药物警戒研究。
BMC Pharmacol Toxicol. 2025 Jul 18;26(1):135. doi: 10.1186/s40360-025-00965-5.
3
Influence of patient age and sex on drug-induced liver injury caused by antiseizure medications: a disproportionality analysis of VigiBase.
患者年龄和性别对抗癫痫药物所致药物性肝损伤的影响:VigiBase数据库的不成比例分析
Int J Clin Pharm. 2025 Jun 4. doi: 10.1007/s11096-025-01935-x.
4
Drug-induced kidney stones: a real-world pharmacovigilance study using the FDA adverse event reporting system database.药物性肾结石:一项使用美国食品药品监督管理局不良事件报告系统数据库的真实世界药物警戒研究。
Front Pharmacol. 2025 Mar 27;16:1511115. doi: 10.3389/fphar.2025.1511115. eCollection 2025.
5
PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance database.与PD1和CTLA4抑制剂相比,PDL1抑制剂可能与同种异体移植排斥反应风险较低相关:世界卫生组织药物警戒数据库分析
Front Immunol. 2025 Jan 22;16:1514033. doi: 10.3389/fimmu.2025.1514033. eCollection 2025.
6
The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline.药物警戒中不成比例性分析的报告:聚焦于READUS-PV指南。
Front Pharmacol. 2024 Nov 27;15:1488725. doi: 10.3389/fphar.2024.1488725. eCollection 2024.
7
Early Detection of Hearing Impairment Signals Post-mRNA COVID-19 Vaccination: A Disproportionality Analysis Study on French Pharmacovigilance Database.mRNA新冠疫苗接种后听力障碍信号的早期检测:基于法国药物警戒数据库的不成比例分析研究
Drug Saf. 2025 Mar;48(3):251-263. doi: 10.1007/s40264-024-01495-5. Epub 2024 Dec 5.
8
Hepatotoxicity of antipsychotics: an exploratory pharmacoepidemiologic and pharmacodynamic study integrating FAERS data and receptor-binding affinities.抗精神病药物的肝毒性:一项整合FAERS数据和受体结合亲和力的探索性药物流行病学和药效学研究。
Front Psychiatry. 2024 Oct 14;15:1479625. doi: 10.3389/fpsyt.2024.1479625. eCollection 2024.
9
In-vivo Toxicity Evaluation of 3-(2-(3,4 dimethoxyphenyl)-2 oxoethylidene) Indolin-2-one (RAJI) in Zebrafish and Mice Model.3-(2-(3,4-二甲氧基苯基)-2 氧代乙基)吲哚啉-2-酮(RAJI)在斑马鱼和小鼠模型中的体内毒性评价。
Asian Pac J Cancer Prev. 2024 Sep 1;25(9):3159-3172. doi: 10.31557/APJCP.2024.25.9.3159.
10
Comparing the adverse effects of ketamine and esketamine between genders using FAERS data.利用美国食品药品监督管理局不良事件报告系统(FAERS)数据比较氯胺酮和艾氯胺酮在不同性别中的不良反应。
Front Pharmacol. 2024 Jul 12;15:1329436. doi: 10.3389/fphar.2024.1329436. eCollection 2024.